US4263429AExpiredUtility

1,2,6-Tri-N-benzyloxycarbonylfortimicin B-4,5-carbamate and 1,2,6-tri-N-acetylfortimicin B-4,5-carbamate

33
Assignee: ABBOTT LABPriority: Sep 26, 1979Filed: Sep 26, 1979Granted: Apr 21, 1981
Est. expirySep 26, 1999(expired)· nominal 20-yr term from priority
Inventors:John S. TadanierJerry R. Martin
C07H 15/224
33
PatentIndex Score
0
Cited by
10
References
3
Claims

Abstract

A fortimicin intermediate selected from the group consisting of 1,2',6'-tri-N-benzyloxycarbonylfortimicin B-4,5-carbamate and 1,2',6'-tri-N-acetylfortimicin A-4,5-carbamate. The compounds are useful as intermediates in the preparation of 2-epi-fortimicin B.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. A fortimicin intermediate selected from the group consisting of 1,2',6'-tri-N-benzyloxycarbonylfortimicin B-4,5-carbamate and 1,2',6'-tri-N-acetylfortimicin B-4,5-carbamate. 
     
     
       2. 1,2',6'-Tri-N-benzyloxycarbonylfortimicin B-4,5-carbamate. 
     
     
       3. 1,2',6'-Tri-N-acetylfortimicin B-4,5-carbamate.

Join the waitlist — get patent alerts

Track US4263429A — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.